These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27574944)

  • 1. Enterocolitis: An Unknown Side Effect of Pazopanib.
    Sharma A; Masood U; Manocha D
    Am J Ther; 2017; 24(4):e490-e491. PubMed ID: 27574944
    [No Abstract]   [Full Text] [Related]  

  • 2. Pazopanib-Associated Transient Ischemic Attack.
    Revuelta-Herrero JL; Escudero-Vilaplana V; Álvarez-Álvarez R; Sanjurjo-Sáez M
    Am J Ther; 2018; 25(3):e393-e394. PubMed ID: 29424756
    [No Abstract]   [Full Text] [Related]  

  • 3. Paradoxical antitumor effects of pazopanib in a cutaneous angiosarcoma patient.
    Hoashi T; Hirabayashi M; Nakajima R; Takahashi N; Saeki H
    J Dermatol; 2017 Sep; 44(9):1078-1079. PubMed ID: 27726177
    [No Abstract]   [Full Text] [Related]  

  • 4. A rare case: Hallucination associated with pazopanib.
    Demirci NS; Erdem GU; Dogan M; Ozdemir NY; Zengin N
    J Cancer Res Ther; 2015; 11(4):961-2. PubMed ID: 26881556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pazopanib: pericardial effusion.
    Prescrire Int; 2014 Nov; 23(154):268. PubMed ID: 25954795
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of pazopanib for local and lung metastases in Stewart-Treves syndrome.
    Hayashi M; Makino T; Mori N; Mizawa M; Shimizu T
    Eur J Dermatol; 2020 Feb; 30(1):68-69. PubMed ID: 32250262
    [No Abstract]   [Full Text] [Related]  

  • 7. Pazopanib: retinal detachment.
    Prescrire Int; 2015 Jan; 24(156):20. PubMed ID: 25729830
    [No Abstract]   [Full Text] [Related]  

  • 8. Bronchopleural fistula arising after commencement of pazopanib for progressive sarcoma.
    Cohen L; Neuhaus S; Chryssidis S; Kotasek D
    ANZ J Surg; 2017 Jul; 87(7-8):E48-E49. PubMed ID: 25556827
    [No Abstract]   [Full Text] [Related]  

  • 9. [Atrial flutter probably related to pazopanib: A case report].
    Puebla Villaescusa A; Díaz Gómez E; Salcedo Mingoarranz ÁL; Ramírez Cruz S; Hidalgo Correas FJ; García Díaz B
    Farm Hosp; 2018 Jan; 42(1):33-34. PubMed ID: 29306315
    [No Abstract]   [Full Text] [Related]  

  • 10. Promising management of pazopanib-induced liver toxicity.
    Vlenterie M; van Erp NP; van der Graaf WT
    Acta Oncol; 2015 Jul; 54(7):1064-6. PubMed ID: 25734660
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment.
    Nakano K; Inagaki L; Tomomatsu J; Motoi N; Gokita T; Ae K; Tanizawa T; Shimoji T; Matsumoto S; Takahashi S
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):357. PubMed ID: 24630810
    [No Abstract]   [Full Text] [Related]  

  • 12. Pazopanib-Associated Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome: A Case Report.
    Singh P; DʼAngelo RN; Huang V
    Am J Ther; 2019; 26(5):e636-e638. PubMed ID: 30946042
    [No Abstract]   [Full Text] [Related]  

  • 13. Pazopanib outscores sunitinib on tolerability.
    Cancer Discov; 2014 Jan; 4(1):OF8. PubMed ID: 24402960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiosarcoma of the scalp successfully treated with pazopanib.
    Tomita H; Koike Y; Asai M; Ogawa F; Abe K; Tanioka M; Utani A
    J Am Acad Dermatol; 2014 Jan; 70(1):e19-21. PubMed ID: 24176520
    [No Abstract]   [Full Text] [Related]  

  • 15. Pazopanib: an alternative in taxane-resistant cutaneous angiosarcoma.
    Fujita M; Endo Y; Fujisawa A; Tanioka M; Kabashima K; Miyachi Y
    Eur J Dermatol; 2014; 24(2):267-8. PubMed ID: 24682601
    [No Abstract]   [Full Text] [Related]  

  • 16. Periosteal Reaction Possibly Induced by Pazopanib: A Case Report and Literature Review.
    Hosokawa T; Hara T; Arakawa Y; Oguma E; Yamada Y
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):e822-e825. PubMed ID: 31567787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unexpected skin ulcer and soft tissue necrosis after the nonconcurrent combination of proton beam therapy and pazopanib: A case of myxofibrosarcoma.
    Uwa N; Terada T; Mohri T; Tsukamoto Y; Futani H; Demizu Y; Okimoto T; Sakagami M
    Auris Nasus Larynx; 2017 Aug; 44(4):484-488. PubMed ID: 27523716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-bowel fistula as a possible complication of pazopanib therapy in retroperitoneal leiomyosarcoma.
    Pereira ROL; Patel PR; Guru PK; Sanghavi DK
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31712231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose administration of oral pazopanib for the treatment of recurrent angiosarcoma.
    Miura H; Shirai H
    Clin Exp Dermatol; 2015 Jul; 40(5):575-7. PubMed ID: 25753734
    [No Abstract]   [Full Text] [Related]  

  • 20. Pazopanib can preserve cosmetic quality of life even in end-stage angiosarcoma.
    Kitamura S; Hata H; Imafuku K; Haga N; Homma E; Shimizu H
    Clin Exp Dermatol; 2015 Dec; 40(8):931-3. PubMed ID: 25817046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.